pharma manufacturing

Lilly Exec: India a Prime Investment Hub for Pharma R&D A man in a suit gesturing towards a futuristic cityscape with DNA helix and data visualizations, representing pharma investment.

A man in a suit gesturing towards a futuristic cityscape with DNA helix and data visualizations, representing pharma investment.

Lilly Exec: India a Prime Investment Hub for Pharma R&D

sivam March 21, 2026

Lilly International President Patrick Johnson sees India as an attractive investment hub, citing faster clinical trial approvals...

Sun Pharma Launches Affordable Semaglutide in India Pharmaceutical products, including boxes and blister packs of "Noveltreat" and "Sematrinity" on a wooden table.

Pharmaceutical products, including boxes and blister packs of "Noveltreat" and "Sematrinity" on a wooden table.

Sun Pharma Launches Affordable Semaglutide in India

sivam March 21, 2026

Sun Pharma introduces Noveltreat & Sematrinity semaglutide in India, offering affordable alternatives for diabetes & weight management....

Indian Drugmakers Battle for Obesity Market Share Pharmaceutical workers in cleanroom attire oversee packaging on a conveyor belt in a modern Indian factory.

Pharmaceutical workers in cleanroom attire oversee packaging on a conveyor belt in a modern Indian factory.

Indian Drugmakers Battle for Obesity Market Share

sivam March 21, 2026

Indian drugmakers compete for obesity market share as generic weight-loss drugs drive prices down, increasing access but...

Alkem Labs Launches Semaglutide in India for Weight Loss Semaglutide injection pens and packaged boxes are arranged on a white surface within a clean, blurred pharmaceutical lab.

Semaglutide injection pens and packaged boxes are arranged on a white surface within a clean, blurred pharmaceutical lab.

Alkem Labs Launches Semaglutide in India for Weight Loss

sivam March 21, 2026

Alkem Labs enters India's weight-loss market with Semaglutide injection, offering a cost-effective solution for diabetes and weight...

Generic Semaglutide: Indian Firms Challenge Novo Nordisk A modern pharmaceutical manufacturing facility with robotic arms and human workers in clean suits overseeing the production of generic semaglutide vials and pens.

A modern pharmaceutical manufacturing facility with robotic arms and human workers in clean suits overseeing the production of generic semaglutide vials and pens.

Generic Semaglutide: Indian Firms Challenge Novo Nordisk

sivam March 21, 2026

Indian firms launch generic semaglutide, challenging Novo Nordisk's Ozempic & Wegovy. Affordable access to diabetes & weight...

Dr. Reddy’s Launches Semaglutide ‘Obeda’ in India Semaglutide injectables and vials on a lab bench with scientists and manufacturing equipment in the background.

Semaglutide injectables and vials on a lab bench with scientists and manufacturing equipment in the background.

Dr. Reddy’s Launches Semaglutide ‘Obeda’ in India

sivam March 21, 2026

Dr. Reddy's Laboratories introduces Obeda, a semaglutide injectable, in India, enhancing their diabetes care portfolio. A new...

Dr. Reddy’s Launches Semaglutide ‘Obeda’ for Diabetes Medical professional with Obeda medication, syringe, and DNA helix in a sterile pharmaceutical manufacturing lab.

Medical professional with Obeda medication, syringe, and DNA helix in a sterile pharmaceutical manufacturing lab.

Dr. Reddy’s Launches Semaglutide ‘Obeda’ for Diabetes

sivam March 21, 2026

Dr. Reddy's Laboratories introduces 'Obeda', a semaglutide version for diabetes management in India. Aims to expand its...

Dr. Reddy’s Launches Generic Semaglutide for Diabetes in India A scientist in a lab coat and blue gloves holding a semaglutide injection, with a holographic display of India and medical icons.

A scientist in a lab coat and blue gloves holding a semaglutide injection, with a holographic display of India and medical icons.

Dr. Reddy’s Launches Generic Semaglutide for Diabetes in India

sivam March 21, 2026

Dr. Reddy's introduces Obeda, a generic semaglutide injection, the first DCGI-approved treatment for Type 2 diabetes in...

Novo Nordisk Monitors Generic Semaglutide Launch in India A professional in a suit stands in a pharmaceutical facility, looking at a tablet displaying market data, with medicine shelves nearby.

A professional in a suit stands in a pharmaceutical facility, looking at a tablet displaying market data, with medicine shelves nearby.

Novo Nordisk Monitors Generic Semaglutide Launch in India

sivam March 20, 2026

Novo Nordisk to monitor generic semaglutide entrants in India after patent expiration. Tracking market strategies amid potential...

Generic Semaglutide: Lower Prices in India Large hands hold pen-like drug injectors over a pile of Indian currency, with happy people and a city skyline.